SARS-CoV-2 Omicron VOC Transmission in Danish Households
Author:
Lyngse Frederik PlesnerORCID, Mortensen Laust HvasORCID, Denwood Matthew J.ORCID, Christiansen Lasse EngboORCID, Møller Camilla HoltenORCID, Skov Robert LeoORCID, Spiess KatjaORCID, Fomsgaard AndersORCID, Lassaunière Maria Magdalena, Rasmussen MortenORCID, Stegger MarcORCID, Nielsen Claus, Sieber Raphael NiklausORCID, Cohen Arieh SierraORCID, Møller Frederik Trier, Overvad MariaORCID, Mølbak KåreORCID, Krause Tyra GroveORCID, Kirkeby Carsten ThureORCID
Abstract
1AbstractThe Omicron variant of concern (VOC) is a rapidly spreading variant of SARS-CoV-2 that is likely to overtake the previously dominant Delta VOC in many countries by the end of 2021.We estimated the transmission dynamics following the spread of Omicron VOC within Danish households during December 2021. We used data from Danish registers to estimate the household secondary attack rate (SAR).Among 11,937 households (2,225 with the Omicron VOC), we identified 6,397 secondary infections during a 1-7 day follow-up period. The SAR was 31% and 21% in households with the Omicron and Delta VOC, respectively. We found an increased transmission for unvaccinated individuals, and a reduced transmission for booster-vaccinated individuals, compared to fully vaccinated individuals. Comparing households infected with the Omicron to Delta VOC, we found an 1.17 (95%-CI: 0.99-1.38) times higher SAR for unvaccinated, 2.61 times (95%-CI: 2.34-2.90) higher for fully vaccinated and 3.66 (95%-CI: 2.65-5.05) times higher for booster-vaccinated individuals, demonstrating strong evidence of immune evasiveness of the Omicron VOC.Our findings confirm that the rapid spread of the Omicron VOC primarily can be ascribed to the immune evasiveness rather than an inherent increase in the basic transmissibility.
Publisher
Cold Spring Harbor Laboratory
Reference27 articles.
1. Potential severity, mitigation, and control of Omicron waves depending on pre-existing immunity and immune evasion;MedRxiv,2021 2. Effect of a nationwide booster vaccine rollout in Israel on SARS-CoV-2 infection and severe illness in young adults;Travel medicine and infectious disease,2021 3. Brandal, L. T. , MacDonald, E. , Veneti, L. , Ravlo, T. , Lange, H. , Naseer, U. , Feruglio, S. , Bragstad, K. , Hungnes, O. , Ødeskaug, L. E. , Hagen, F. , Hanch-Hansen, K. E. , Lind, A. , Watle, S. V. , Taxt, A. M. , Johansen, M. , Vold, L. , Aavitsland, P. , Nygård, K. , & Madslien, E. H. (2021). Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021. medRxiv. 4. Callaway, E. , Ledford, H. , et al. (2021). How bad is Omicron? What scientists know so far. Nature, 537. 5. Cele, S. , Jackson, L. , Khan, K. , Khoury, D. S. , Moyo-Gwete, T. , Tegally, H. , Scheepers, C. , Amoako, D. , Karim, F. , Bernstein, M. , et al. (2021). SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. medRxiv.
Cited by
113 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|